Join us on Tuesday, June 11 as Nic Brentlinger discusses the surprising, unanimous Supreme Court decision of Helsinn v. Teva.
Nic will discuss nuances of the phrase “or otherwise available to the public” under Section 102(a)(1) in light of the Supreme Court’s ruling and will give practice tips for how to safeguard technology to ensure protection against inadvertent disclosures.
Nic is an attorney at Dinsmore & Shohl with a degree in Chemical Engineering, who previously worked on designing and implementing pharmaceuticals and manufacturing process lines. Nic has a wealth of experience in preparing, filing and prosecuting domestic and international patent applications. His practice involves every step of obtaining protection and managing patent portfolios, from conducting due diligence analysis to handling interference proceedings to drafting right-to-use and invalidity opinions. He also has extensive experience reviewing and drafting licensing agreements, having worked with clients in a variety of industries, including Fortune 500 companies.
On Tuesday, April 23 at Arnold’s Bar and Grill we welcomed The Slants band back to Cincinnati!
At this CincyIP special event, The Slants frontman Simon Tam provided an update on the path to winning Matal v. Tam, and the legal battle that led to the Supreme Court holding that the disparagement clause of the Trademark Act violates the First Amendment’s Free Speech Clause.
Join us on Thursday,April 11 as Patrick McManamny presents strategies for securing patent rights in Australia and neighboring countries.
Mr. McManamny’s remarks will include information on how to rapidly obtain grant of enforceable rights that are likely to stand up to a challenge, as well as options for challenging or preventing grant of competitors’ patents.
Mr. McManamny is a partner in the life sciences group of the Australian patent and trademark firm FB Rice, where his practice focuses on due diligence and freedom-to-operate analysis, particularly in the field of bio-pharmaceuticals. He regularly works with clients throughout the world to develop go-to-market strategies, including invalidity positions of third-party patents. In addition to being a patent attorney in Australia and New Zealand, Mr. McManamny holds a PhD in molecular biology and physiology.